MINERALYS THERAPEUTICS INC (MLYS) Stock Cash Flow
NASDAQ:MLYS - Nasdaq - US6031701013 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -177.81M | -71.90M | -29.80M | -19.41M | -3.43M | |||
| Depreciation Amortization | 43.00K | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 9.52M | -7.47M | 772.00K | 4.08M | 480.00K | |||
| Other non cash items | 1.93M | -1.80M | -194.00K | 764.00K | 483.00K | |||
| OPERATING CASH FLOW | -166.31M | -81.17M | -29.22M | -14.56M | -2.46M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -96.00K | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | 115.06M | -160.47M | -21.76M | N/A | N/A | |||
| INVESTING CASH FLOW | 114.96M | -160.47M | -21.76M | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 3.85M | |||
| Stock Issued/Repurchased | 116.58M | 203.25M | 129.65M | 23.81M | -20.00K | |||
| Other Financing Activity | -435.00K | N/A | -1.63M | N/A | N/A | |||
| FINANCING CASH FLOW | 116.14M | 203.25M | 128.02M | 23.81M | 3.83M | |||
| CHANGE IN CASH | 64.79M | -38.40M | 77.04M | 9.25M | 1.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -166.31M | -81.17M | -29.22M | -14.56M | -2.46M | |||
| Capital Expenditure | -96.00K | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -166.41M | -81.17M | -29.22M | -14.56M | -2.46M | |||
All data in USD